Orelabrutinib Placebo

DRUG2 trials

Sponsors

Beijing InnoCare Pharma Tech Co., Ltd., InnoCare Pharma Inc.

Conditions

Mantle Cell LymphomaSystemic Lupus Erythematosus, SLE

Phase 2

Evaluate the Efficacy and Safety of Orelabrutinib in Adult Patients With Systemic Lupus Erythematosus

RecruitingNCT05688696

Beijing InnoCare Pharma Tech Co., Ltd.Systemic Lupus Erythematosus, SLE

Start: 2023-04-29End: 2026-05-30Target: 186Updated: 2024-08-16

Phase 3

A Global Phase 3 Study of Orelabrutinib+BR Vs.BR in Pts with TN MCL

RecruitingNCT06363994

InnoCare Pharma Inc.Mantle Cell Lymphoma

Start: 2024-05-29End: 2032-06-25Target: 476Updated: 2024-12-27